13F Holdings
中文EN

Fairmount Funds Management LLC

WEST CONSHOHOCKEN PA · SEC CIK 0001802528

2026Q22026Q1 9 earlier quarters 🔒
$1.51B2026Q2 reported value
12Positions
97.6%Top 10 weight · largest 23.3%
1 / 1New / sold out
Reported value over time$1.51B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

ORKA 23.3%
DNTH 16.3%
DMRA 15.0%
COGT 14.1%
JBIO 6.7%
ELVN 6.2%
VRDN 6.2%
ZBIO 4.0%
CBIO 3.3%
APOGEE THERAPE 2.6%

2026Q2 top buys estimated at quarter-end value

VRDN Added+$21.61M
FTH New+$18.05M

2026Q2 top sells estimated at quarter-end value

SYRE Sold out-$202.67M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
ORKA ORUKA THERAPEUTICS INC $352.63M23.31%3,705,262 00.0% — Unchanged
DNTH DIANTHUS THERAPEUTICS INC $247.33M16.35%2,537,191 00.0% — Unchanged
DMRA DAMORA THERAPEUTICS INC $226.63M14.98%8,713,000 00.0% — Unchanged
COGT COGENT BIOSCIENCES INC $212.98M14.08%5,503,418 00.0% — Unchanged
JBIO JADE BIOSCIENCES INC $101.18M6.69%4,553,494 00.0% — Unchanged
ELVN ENLIVEN THERAPEUTICS INC $94.17M6.22%1,855,644 00.0% — Unchanged
VRDN VIRIDIAN THERAPEUTICS INC $93.52M6.18%5,090,928 1,176,47030.1% $21.61M Added
ZBIO ZENAS BIOPHARMA INC $59.87M3.96%2,359,025 00.0% — Unchanged
CBIO CRESCENT BIOPHARMA INC. $49.46M3.27%2,747,866 00.0% — Unchanged
— APOGEE THERAPEUTICS INC $39.64M2.62%298,647 00.0% — Unchanged
FTH FAETH THERAPEUTICS INC $18.05M1.19%722,020 722,020— $18.05M New
IKT INHIBIKASE THERAPEUTICS INC $17.51M1.16%8,625,000 00.0% — Unchanged
SYRE SPYRE THERAPEUTICS INC $00.00%0 -4,018,101-100.0% -$202.67M Sold out